The lungs of MSC treated mice had significantly lower levels of BPD injury related to proteins associated with immunomodulation (CX3CL1, TNFα, TIM‐1, hepassocin, neprilysin), cell survival (osteoprotegerin), and wound healing (MMP‐2, LIF). This evidence concerns the gene FGL1 and bronchopulmonary dysplasia.